Explorez notre collection de documents PDF et enrichissez vos connaissances dès maintenant !
retour
No commitment, no certificate: loose combinations and the SPC regulation
Article Brevets | 06/02/26 | 1 min. | François Pochart Pierre-Olivier Ally Mayeul Ottaviani
Sciences de la vie & Santé
Read the full article on https://www.iam-media.com/article/no-commitment-no-certificate-loose-combinations-and-the-spc-regulation
In this article, François Pochart, Pierre‑Olivier Ally and Mayeul Ottaviani analyse a key issue for pharma innovators: the persistent ineligibility of “loose combinations” for SPC protection.
Recent decisions in France, the UK and Germany all point in the same direction — and the upcoming SPC Regulation reform leaves this gap untouched.
For companies developing combination therapies, the takeaway is clear: anticipating IP and regulatory hurdles is now more critical than ever.
The article breaks down the legal landscape and its strategic implications for market access, lifecycle management and innovation planning.
In this article, François Pochart, Pierre‑Olivier Ally and Mayeul Ottaviani analyse a key issue for pharma innovators: the persistent ineligibility of “loose combinations” for SPC protection.
Recent decisions in France, the UK and Germany all point in the same direction — and the upcoming SPC Regulation reform leaves this gap untouched.
For companies developing combination therapies, the takeaway is clear: anticipating IP and regulatory hurdles is now more critical than ever.
The article breaks down the legal landscape and its strategic implications for market access, lifecycle management and innovation planning.